Additionally, we found that, when the transcriptomic data was combined with the mutation profiles available for each patient in bladder cancer, a linear alignment by TcB also predicted that the mutations exhibited predictable evolutionary patterns (Figure S8). Here, PKM is linked to urinary bladder carcinoma.